Search

everythinglearnresearchcommunity

for

Search:↓

Latanoprost 0.1% may effectively treat hair loss.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Latanoprost therapy potentially caused a woman's white hair to darken again.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Ruxolitinib treatment may cause eyelash growth.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Levetiracetam and valproate sodium both reduce seizures when added to lamotrigine, but levetiracetam has fewer side effects.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

More research is needed to understand if GLP-1 agonists affect hair health.

Combining lifestyle changes with personalized medication is crucial for better managing obesity in PCOS.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Pentoxifylline effectively improves pretibial pruritic papular dermatitis.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

The new treatment using tiny lipid carriers to deliver minoxidil and latanoprost directly to hair follicles shows promise for alopecia.

Using a special laser and skin medication together successfully cleared a skin condition in a pregnant woman.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.